Welcome to the future, the new world where production goes by the name integration.
This is the new pharmaceutical production frontier, where Prexima and Croma are one.
Live Event • Can't stop the future
September 26-27, 2019 • Bologna, Italy
IMA Active has the pleasure of inviting you to the event that aims at bringing together pharmaceutical companies, regulators and academics to look at accelerating adoption of Continuous Manufacturing in Oral Solid Dosage forms.
Continuous Manufacturing supports improvement of pharmaceutical products in terms of potency, effectiveness, and safety, by means of accurate process control. Croma is IMA’s first step towards continuous.
The increasing interest of the pharmaceutical industry in Continuous Manufacturing aims at achieving total quality through a flexible and sustainable production. At IMA, we believe that our commitment can support the change to Continuous Manufacturing.
ODY is a pilot project that uses artificial intelligence and machine learning to facilitate online interaction between IMA and its website users. ODY is continuously learning and expanding its knowledge base over time, interaction after interaction. For further information, it is always possible to ask ODY to get in touch with a specialist from IMA staff.